Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-05-10 | New | $3,999,942 | $3,999,942 | Equity Only | 06b | SEC link |
| 2024-02-13 | New | $2,502,717 | $2,502,717 | Other | 06b | SEC link |
| 2023-04-10 | New | $4,003,205 | $4,003,205 | Equity Only | 06b | SEC link |
| 2023-01-19 | New | $2,500,000 | $2,500,000 | Other | 06b | SEC link |
| 2022-05-20 | New | $2,356,127 | $2,356,127 | Other | 06b | SEC link |
| 2020-01-28 | New | $7,555,553 | $7,555,553 | Other | 06b | SEC link |
| 2017-05-31 | New | $42,000 | $42,000 | Equity Only | 06b | SEC link |
| 2016-12-19 | New | $20,000,000 | $20,000,000 | Equity Only | 06b | SEC link |
| 2016-05-23 | New | $1,080,000 | $1,080,000 | Equity Only | 06b | SEC link |
| 2014-12-04 | Amended | $10,000,000 | $0 | Debt Only | 06b | SEC link |
| 2014-10-31 | New | $10,000,000 | $10,000,000 | Debt Only | 06b | SEC link |
| 2013-04-10 | New | $1,778,000 | $1,778,000 | Equity and Debt | 06 | SEC link |
| 2010-01-05 | New | $1,500,000 | $1,500,000 | Equity Only | 05 46 | SEC link |
| Name | Role |
|---|---|
| Kenneth Carter | Director, Executive |
| John Conron | Executive |
| Cristina Csimma | Director |
| Richard Daly | Director, Executive |
| Stephanie Diaz | Director |
| J.D. Finley | Director, Executive |
| Jd Finley | Executive |
| Margery Fischbein | Director |
| I. Richard Garr | Director, Executive |
| Richard Garr | Director |
| Mary Ann Gray | Director |
| Thomas Hallam | Director, Executive |
| Karl Johe | Director, Executive |
| Mitchell Jones | Executive |
| Jonathan Lloyd Jones | Executive |
| David Mazzo | Director |
| Robert Mc Rae | Executive |
| James Neal | Director |
| Scott Ogilvie | Director |
| William Oldaker | Director |
| Herbert Slade | Executive |
| Sandford Smith | Director |
| Catherine Sohn | Director |
| Robert Trenschel | Director |
| Binxian Wei | Director |
| Stanley Westreich | Director |
| Donald Williams | Director |